Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tzelepi, E.
Right arrow Articles by Tzouvelekis, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tzelepi, E.
Right arrow Articles by Tzouvelekis, L. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1999) 43, 745-746
© 1999 The British Society for Antimicrobial Chemotherapy

Correspondence

Erythromycin resistance amongst group A ß-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece

J Antimicrob Chemother 1999; 43: 745-746

E. Tzelepia,*, G. Koupparib, A. Mavroidia, A. Zaphiropouloub and L. S. Tzouvelekisa

a Department of Bacteriology, Hellenic Pasteur Institute, 127 Vass. Sofias, 11521 Athens; b Microbiology Laboratory of the ‘P. & A. Kyriakou’ Children's Hospital of Athens, Athens, Greece

Sir,

Group A ß-haemolytic streptococci (GABHS) remain highly susceptible to penicillin. Most isolates are also susceptible to erythromycin, which is the principal alternative to penicillin as therapy of group A streptococcal pharyngo-tonsillitis in patients allergic to ß-lactams. However, reports of the failure of penicillin to eradicate GABHS in vivo and, more importantly, the emergence of erythromycin resistance amongst GABHS during the past decade, have focused attention on the antibiotic susceptibility patterns of these pathogens. 1 The aim of . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
S. L. Block
Comparative Tolerability, Safety and Efficacy of Tablet Formulations of Twice-Daily Clarithromycin 250 mg versus Once-Daily Extended-Release Clarithromycin 500 mg in Pediatric and Adolescent Patients
Clinical Pediatrics, September 1, 2006; 45(7): 641 - 648.
[Abstract] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
I. N. Grivea, A. Al-Lahham, G. D. Katopodis, G. A. Syrogiannopoulos, and R. R. Reinert
Resistance to Erythromycin and Telithromycin in Streptococcus pyogenes Isolates Obtained between 1999 and 2002 from Greek Children with Tonsillopharyngitis: Phenotypic and Genotypic Analysis
Antimicrob. Agents Chemother., January 1, 2006; 50(1): 256 - 261.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Cresti, M. Lattanzi, A. Zanchi, F. Montagnani, S. Pollini, C. Cellesi, and G. M. Rossolini
Resistance Determinants and Clonal Diversity in Group A Streptococci Collected during a Period of Increasing Macrolide Resistance
Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1816 - 1822.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
C. Betriu, M. Redondo, M. L. Palau, A. Sánchez, M. Gómez, E. Culebras, A. Boloix, and J. J. Picazo
Comparative In Vitro Activities of Linezolid, Quinupristin-Dalfopristin, Moxifloxacin, and Trovafloxacin against Erythromycin-Susceptible and -Resistant Streptococci
Antimicrob. Agents Chemother., July 1, 2000; 44(7): 1838 - 1841.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
E. Bingen, F. Fitoussi, C. Doit, R. Cohen, A. Tanna, R. George, C. Loukil, N. Brahimi, I. Le Thomas, and D. Deforche
Resistance to Macrolides in Streptococcus pyogenes in France in Pediatric Patients
Antimicrob. Agents Chemother., June 1, 2000; 44(6): 1453 - 1457.
[Abstract] [Full Text]